Gadolinium-based Contrast Media, Cerebrospinal Fluid and the Glymphatic System: Possible Mechanisms for the Deposition of Gadolinium in the Brain

Overview

Journal Magn Reson Med Sci

Specialty Radiology

Date 2018 Jan 26

PMID 29367513

Citations 50

Authors

Toshiaki Taoka

Shinji Naganawa

Affiliations

Soon will be listed here.

Abstract

After Kanda's first report in 2014 on gadolinium (Gd) deposition in brain tissue, a considerable number of studies have investigated the explanation for the observation. Gd deposition in brain tissue after repeated administration of gadolinium-based contrast medium (GBCM) has been histologically proven, and chelate stability has been shown to affect the deposition. However, the mechanism for this deposition has not been fully elucidated. Recently, a hypothesis was introduced that involves the 'glymphatic system', which is a coined word that combines 'gl' for glia cell and 'lymphatic' system. According to this hypothesis, the perivascular space functions as a conduit for cerebrospinal fluid to flow into the brain parenchyma. The perivascular space around the arteries allows cerebrospinal fluid to enter the interstitial space of the brain tissue through water channels controlled by aquaporin 4. The cerebrospinal fluid entering the interstitial space clears waste proteins from the tissue. It then flows into the perivascular space around the vein and is discharged outside the brain. In addition to the hypothesis regarding the glymphatic system, some reports have described that after GBCM administration, some of the GBCM distributes through systemic blood circulation and remains in other compartments including the cerebrospinal fluid. It is thought that the GBCM distributed into the cerebrospinal fluid cavity via the glymphatic system may remain in brain tissue for a longer duration compared to the GBCM in systemic circulation. Glymphatic system may of course act as a clearance system for GBCM from brain tissue. Based on these findings, the mechanism for Gd deposition in the brain will be discussed in this review. The authors speculate that the glymphatic system may be the major contributory factor to the deposition and clearance of gadolinium in brain tissue.

Citing Articles

Analyzing the relationship between specific brain structural changes and the diffusion tensor image analysis along the perivascular space index in idiopathic normal pressure hydrocephalus.

Hasegawa S, Yoshimaru D, Hayashi N, Shibukawa S, Takagi M, Murai H J Neurol. 2024; 272(1):56.

PMID: 39666072 DOI: 10.1007/s00415-024-12850-y.

The Cerebrovascular Side of Plasticity: Microvascular Architecture across Health and Neurodegenerative and Vascular Diseases.

Zedde M, Pascarella R Brain Sci. 2024; 14(10).

PMID: 39451997 PMC: 11506257. DOI: 10.3390/brainsci14100983.

Glymphatic dysfunction in multiple sclerosis and its association with disease pathology and disability.

Bayoumi A, Hasan K, Thomas J, Yazdani A, Lincoln J Mult Scler. 2024; 30(13):1609-1619.

PMID: 39344166 PMC: 11568644. DOI: 10.1177/13524585241280842.

Gadolinium Contrast Agent Deposition in Children.

Ouyang M, Bao L J Magn Reson Imaging. 2024; 61(1):70-82.

PMID: 38597340 PMC: 11645493. DOI: 10.1002/jmri.29389.

Enlarged Perivascular Space and Index for Diffusivity Along the Perivascular Space as Emerging Neuroimaging Biomarkers of Neurological Diseases.

Zhang J, Liu S, Wu Y, Tang Z, Wu Y, Qi Y Cell Mol Neurobiol. 2023; 44(1):14.

PMID: 38158515 PMC: 11407189. DOI: 10.1007/s10571-023-01440-7.

References

Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J . Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. Radiology. 2015; 276(1):228-32. DOI: 10.1148/radiol.2015142690. View

Bauer K, Lathrum A, Raslan O, Kelly P, Zhou Y, Hewing D . Do Gadolinium-Based Contrast Agents Affect F-FDG PET/CT Uptake in the Dentate Nucleus and the Globus Pallidus? A Pilot Study. J Nucl Med Technol. 2016; 45(1):30-33. DOI: 10.2967/jnmt.116.180844. View

Ohata K, Marmarou A, Povlishock J . An immunocytochemical study of protein clearance in brain infusion edema. Acta Neuropathol. 1990; 81(2):162-77. DOI: 10.1007/BF00334505. View

Murata N, Gonzalez-Cuyar L, Murata K, Fligner C, Dills R, Hippe D . Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function. Invest Radiol. 2016; 51(7):447-53. DOI: 10.1097/RLI.0000000000000252. View

Tarasoff-Conway J, Carare R, Osorio R, Glodzik L, Butler T, Fieremans E . Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015; 11(8):457-70. PMC: 4694579. DOI: 10.1038/nrneurol.2015.119. View

Radbruch A, Weberling L, Kieslich P, Eidel O, Burth S, Kickingereder P . Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology. 2015; 275(3):783-91. DOI: 10.1148/radiol.2015150337. View

Taoka T, Masutani Y, Kawai H, Nakane T, Matsuoka K, Yasuno F . Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases. Jpn J Radiol. 2017; 35(4):172-178. DOI: 10.1007/s11604-017-0617-z. View

Radbruch A, Haase R, Kieslich P, Weberling L, Kickingereder P, Wick W . No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents. Radiology. 2016; 282(3):699-707. DOI: 10.1148/radiol.2016162241. View

Radbruch A, Weberling L, Kieslich P, Hepp J, Kickingereder P, Wick W . High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol. Invest Radiol. 2015; 50(12):805-10. DOI: 10.1097/RLI.0000000000000227. View

10.

Kanda T, Oba H, Toyoda K, Kitajima K, Furui S . Brain gadolinium deposition after administration of gadolinium-based contrast agents. Jpn J Radiol. 2015; 34(1):3-9. DOI: 10.1007/s11604-015-0503-5. View

11.

Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T . Imaging of Ménière's disease after intravenous administration of single-dose gadodiamide: utility of subtraction images with different inversion time. Magn Reson Med Sci. 2012; 11(3):213-9. DOI: 10.2463/mrms.11.213. View

12.

Weberling L, Kieslich P, Kickingereder P, Wick W, Bendszus M, Schlemmer H . Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration. Invest Radiol. 2015; 50(11):743-8. DOI: 10.1097/RLI.0000000000000206. View

13.

Radbruch A, Weberling L, Kieslich P, Hepp J, Kickingereder P, Wick W . Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Invest Radiol. 2016; 51(11):683-690. DOI: 10.1097/RLI.0000000000000308. View

14.

Koh L, Zakharov A, Johnston M . Integration of the subarachnoid space and lymphatics: is it time to embrace a new concept of cerebrospinal fluid absorption?. Cerebrospinal Fluid Res. 2005; 2:6. PMC: 1266390. DOI: 10.1186/1743-8454-2-6. View

15.

Errante Y, Cirimele V, Mallio C, Di Lazzaro V, Zobel B, Cosimo Quattrocchi C . Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol. 2014; 49(10):685-90. DOI: 10.1097/RLI.0000000000000072. View

16.

Naganawa S, Suzuki K, Yamazaki M, Sakurai Y . Serial scans in healthy volunteers following intravenous administration of gadoteridol: time course of contrast enhancement in various cranial fluid spaces. Magn Reson Med Sci. 2014; 13(1):7-13. DOI: 10.2463/mrms.2013-0056. View

17.

Kanda T, Nakai Y, Oba H, Toyoda K, Kitajima K, Furui S . Gadolinium deposition in the brain. Magn Reson Imaging. 2016; 34(10):1346-1350. DOI: 10.1016/j.mri.2016.08.024. View

18.

Nedergaard M, Goldman S . BRAIN DRAIN. Sci Am. 2016; 314(3):44-9. PMC: 5347443. DOI: 10.1038/scientificamerican0316-44. View

19.

Rasschaert M, Idee J, Robert P, Fretellier N, Vives V, Violas X . Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats. Invest Radiol. 2017; 52(5):255-264. PMC: 5383202. DOI: 10.1097/RLI.0000000000000339. View

20.

Stojanov D, Aracki-Trenkic A, Vojinovic S, Benedeto-Stojanov D, Ljubisavljevic S . Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based.... Eur Radiol. 2015; 26(3):807-15. DOI: 10.1007/s00330-015-3879-9. View